$EXEL Company News Biotechs still sliding, but Wall

New Post Public Reply Private Reply Replies (0) Message Board

Apr 26, 2014 at 11:49 AM

$EXEL Company News

Biotechs still sliding, but Wall Street says don't hit panic button just yet 2:43 p.m. March 26, 2014 - Russ Britt
HMA’s pre-emptive strike against ‘60 Minutes’ 5:44 p.m. Nov. 30, 2012 - Russ Britt
Chipotle vs. Taco Bell: testing Einhorn's thesis 6:37 a.m. Oct. 4, 2012 - The Trading Deck
Exelixis prices stock offering at 0.7% discount 12:21 p.m. Aug. 9, 2012 - MarketWatch.com
Exelixis slides 12% on stock, debt offering 3:39 p.m. Aug. 6, 2012 - Val Brickates Kennedy
FDA to speed Exelixis thyroid-cancer-drug review 6:35 a.m. July 30, 2012 - MarketWatch.com
Stocks to watch Thursday: GM, Agilent, NetApp 7:51 a.m. Feb. 16, 2012 - MarketWatch
Exelixis licenses cancer-drug R&D to Merck & Co. 8:26 a.m. Dec. 21, 2011 - MarketWatch.com
Loathe that investment theme? Perfect! 1:03 p.m. Nov. 8, 2011 - The Trading Deck
Exelixis plunges on drug study woes 12:05 p.m. Nov. 1, 2011 - Val Brickates Kennedy
Stocks to watch Tuesday: Exelixis, DirecTV, Leap 6:46 a.m. Nov. 1, 2011 - MarketWatch
Exelixis slides, Allstate up in after-hours trade 6:48 p.m. Oct. 31, 2011 - Carla Mozee
Exelixis shares fall without FDA study commentary 6:05 p.m. Oct. 31, 2011 - Wallace Witkowski
Exelixis shares resume trading, drop 35% 5:44 p.m. Oct. 31, 2011 - Carla Mozee
Exelixis rallies 21% on drug study 11:46 a.m. Oct. 24, 2011 - Val Brickates Kennedy
Icahn reports new stakes in Vector Group, El Paso 7:52 p.m. Aug. 15, 2011 - MarketWatch.com
ASCO studies shake up drug stocks 4:17 p.m. June 7, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 6:50 p.m. June 6, 2011 - Kate Gibson
Exelixis, Sunesis lead drug stocks lower 3:42 p.m. June 6, 2011 - Val Brickates Kennedy
Exelixis sinks 18% on drug-safety concerns 3:21 p.m. June 6, 2011 - Val Brickates Kennedy

First Week Of June 21st Options Trading For Exelixis (EXEL) 11:19 a.m. April 23, 2014 - TheStreet.com
Biotech Stock Roundup: Biogen Drug Approved, Exelixis Tumbles on Study Update - Analyst Blog 10:43 a.m. April 2, 2014 - Zacks.com
Exelixis' Cometriq Approved in the EU - Analyst Blog 6:00 p.m. March 27, 2014 - Zacks.com
Trade-Ideas: Exelixis (EXEL) Is Today's "Dead Cat Bounce" Stock 9:45 a.m. March 27, 2014 - TheStreet.com
Interesting EXEL Put And Call Options For November 22nd 12:13 p.m. March 26, 2014 - TheStreet.com
Disappointment Over Prostate Cancer Drug Study Weigh Heavily on Exelixis 11:42 a.m. March 26, 2014 - TheStreet.com
Exelixis Enters the Danger Zone 11:35 a.m. March 26, 2014 - 247WallSt.com
Mid-Day Market Update: Five Below Jumps On Upbeat Results; Exelixis Shares Decline 11:28 a.m. March 26, 2014 - benzinga.com
Exelixis Urged to Continue Studying Prostate Cancer Treatment 9:27 a.m. March 26, 2014 - The Wall Street Journal Interactive Edition
Mid-Morning Market Update: Markets Open Higher; Francesca's Issues Downbeat Q1 Forecast 9:24 a.m. March 26, 2014 - benzinga.com
Stocks Hitting 52-Week Lows 9:22 a.m. March 26, 2014 - benzinga.com
Exelixis (EXEL) Trading With Heavy Volume Before Market Open 8:46 a.m. March 26, 2014 - TheStreet.com
Exelixis trial for prostate-cancer drug given OK to continue 7:37 a.m. March 26, 2014 - Seeking Alpha
4 Reasons To Be Bullish On Exelixis In The Near Term 10:11 a.m. March 25, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I Want to Buy Time Warner 6:00 a.m. March 14, 2014 - TheStreet.com
Cramer's Lightning Round - I Don't Know What Annaly Is Up To (3/13/14) 5:23 a.m. March 14, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Us vs. Them 7:58 p.m. March 13, 2014 - TheStreet.com
Exelixis Q4 Loss In Line with Expectations - Analyst Blog 12:04 p.m. Feb. 21, 2014 - Zacks.com
Exelixis CEO Discusses Q4 2013 Results - Earnings Call Transcript 11:37 p.m. Feb. 20, 2014 - Seeking Alpha
Exelixis, Inc. Discusses Q4 2013 Results (Webcast) 4:55 p.m. Feb. 20, 2014 - Seeking Alpha

Exelixis to Release First Quarter 2014 Financial Results on Thursday, May 1, 2014 4:07 p.m. April 21, 2014 - BusinessWire - BZX
Thyroid Cancer Global Clinical Trials Review, H2, 2013 1:29 p.m. April 9, 2014 - PR Newswire - PRF
European Commission Approves Exelixis Inc.'s Therapy for Thyroid Cancer 2:01 p.m. April 4, 2014 - ACCESSWIRE
King Digital Crushed In Its First Day of Trading; Exelixis Shares Fall 40 Percent 12:11 a.m. March 27, 2014 - ACCESSWIRE
Exelixis Provides Update on Ongoing COMET-1 Phase 3 Pivotal Trial in Men with Metastatic Castration-Resistant Prostate Cancer 7:18 p.m. March 25, 2014 - BusinessWire - BZX
Cometriq(R) approved in Europe for the treatment of progressive, unresectable locally advanced or metastatic medullary thyroid carcinoma. 7:02 a.m. March 25, 2014 - Thomson Reuters ONE
Exelixis Receives Approval for COMETRIQ® (Cabozantinib) in the European Union for Treatment of Progressive, Unresectable Locally Advanced or Metastatic Medullary Thyroid Carcinoma 6:01 a.m. March 25, 2014 - BusinessWire - BZX
Pre-Market Pulse - Health Care Sector Stocks -- Research on Exelixis, StemCells, Dendreon, and Vivus 10:46 a.m. March 24, 2014 - PR Newswire - PRF
Exelixis Announces Webcast of March 4 Presentation at the 34th Annual Cowen and Company Health Care Conference 8:56 p.m. Feb. 26, 2014 - BusinessWire - BZX
Exelixis Announces Fourth Quarter and Full Year 2013 Financial Results 5:15 p.m. Feb. 20, 2014 - BusinessWire - BZX
Exelixis Appoints Executive Vice President and General Counsel 6:27 p.m. Feb. 12, 2014 - BusinessWire - BZX
Exelixis Announces February 20th Webcast of Fourth Quarter and Full Year 2013 Financial Results Conference Call 5:35 p.m. Feb. 10, 2014 - BusinessWire - BZX
Exelixis Announces Webcasts of Investor Conference Presentations in February 6:48 p.m. Jan. 31, 2014 - BusinessWire - BZX
Exelixis Announces Pricing of Overnight Offering of 10,000,000 Shares of Common Stock 9:33 a.m. Jan. 23, 2014 - BusinessWire - BZX
Exelixis Launches Proposed Overnight Public Offering of Common Stock 5:01 p.m. Jan. 22, 2014 - BusinessWire - BZX
Honigman leads client to victory in U.S. Court of Appeals patent term adjustment ruling 8:08 a.m. Jan. 17, 2014 - GlobeNewswire
Unaudited Results, Partnerships, and Stock Price Movements - Research Report on Cubist, Novavax, Exelixis, BioCryst, and Foundation Medicine 9:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
Upcoming Conference Participations, Cash Dividends, and Share Price Movements - Research Report on Johnson & Johnson, Boston Scientific, NuVasive, Exelixis, and Healthways 9:00 a.m. Jan. 7, 2014 - PR Newswire
Clinical Study Results, Pending Applications, Trial Updates, and Discontinued Trials - Research Report on ICU Medical, Exelixis, Cempra, Exact Sciences, and Onconova 9:00 a.m. Dec. 25, 2013 - PR Newswire
COMETRIQ(R) (cabozantinib) Receives Positive Opinion from European Committee for Medicinal Products for Human Use for Progressive, Unresectable Locally Advanced or Metastatic Medullary Thyroid Carcinoma 5:21 p.m. Dec. 19, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Emdoor’s Rugged Devices Fuel Industry Growth Globally

Emdoor Information: A Sturdy Path in Rugged Computing Dive into the heart of the rugged computing terrain, and you may very well run into Emdoor Information—an 18-year-old titan from Shenzhen that’s carved its niche on the backs of rugged tablets, laptops, and handhelds. Publicly listed since 2023 on China’s A-share main board, Emdoor isn't just any player in this...

Young Visionaries Win Junior Medals at STARMUS VIII

Fresh from the Canary Islands' shores, STARMUS VIII has lifted the veil on two young powerhouses shaping tomorrow—Valeria Corrales and Aneeshwar Kunchala. These two have snagged coveted honors, crowning them as champions of their generation. Igniting Passion for Science and the Environment Valeria Corrales isn't just another face in the crowd; she’s the force behind a...

ONLYOFFICE 10.0 Boosts AI and Security Features

A Fresh Look at ONLYOFFICE 10.0's Game-Changing Update Outta the gates swinging, ONLYOFFICE dropped their latest 10.0 update. This one ain't just your average software facelift—it's packing some serious heat with AI enhancements, brand spanking new modular apps, and beefed-up security features that'll make anyone dealing with sensitive data breathe a little easier. AI...

Kexing Biopharm Expands Global Reach at CPHI Milan

Kexing Biopharm's Showstopper Moment in Milan Call it a strategic blowout or just audacious timing—Kexing Biopharm's move at the CPHI Milan 2026 has painted a clear picture. From October 6th to 8th, Milan was the stage where Kexing rolled out its showcase, bragging about a pipeline that screams innovation and possibility. And let’s be honest, their timing couldn’t...

Retail Trading Platforms Report Record Growth in 2026

A Boom in Self-Directed Investing Times are changing, folks. More people than ever are taking finance into their own hands, wielding smartphones like fiscal swords in the name of self-directed investment. No middlemen, no fancy office, just straight-up trading from wherever you might be perched. Four major platforms now boast over 41 million funded accounts combined, each...

Haag-Streit Debuts Innovative Octopus 910 Perimeter at AAO

Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...

New Docs Spotlight Psychiatry on World Mental Health Day

Unmasking Mental Health on the Global Stage Hold onto your hats, folks. The Scientology Network is cranking up the heat this World Mental Health Day. On October 10, they’re rolling out a program that puts the spotlight on CCHR’s crusade against what they see as dark forces in the psychiatric industry. It’s a marathon of documentaries that dives into allegations of...

CenterPoint Deploys Crews for Hurricane Aid Relief

CenterPoint’s Commitment Amidst Crisis Now, when a hurricane slams into the coast, it’s go time for everyone in the game. CenterPoint Energy, never one to sit on the sidelines, is showing up with a hefty squad to help fix the mess left by Hurricane Isaias. A robust 355-strong team is heading out to assist with power restoration down there in Florida. This isn’t just...

Kailas Campaign Binds Climbers with Gear, Trust

Embracing the Spirit of Climbing Connections Alright, so when's the last time you saw a brand digging into the human side of one rugged sport like climbing? That's where Kailas steps in, pulling us beyond gear talk into the trust and camaraderie that defines climbing. Their latest effort—dubbed “Stay Warm, Stay Together”—goes beyond mere technical prowess by...

Zoomlion Boosts Mining Gear Amid Global Revenue Surge

An Ambitious Expansion Overhaul Alright, let's talk Zoomlion Heavy Industry Science & Technology Co., Ltd. They're not just making a splash; they're wading knee-deep into expanding their mining machinery operations and taking charge in international markets. You see, in the first half of 2026, this Chinese behemoth saw its mining machinery business skyrocket by over...